NorthCrest Asset Manangement LLC lowered its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 6.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 152,795 shares of the company's stock after selling 10,741 shares during the period. NorthCrest Asset Manangement LLC's holdings in Procter & Gamble were worth $24,574,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in PG. Brighton Jones LLC boosted its position in shares of Procter & Gamble by 51.5% during the fourth quarter. Brighton Jones LLC now owns 40,068 shares of the company's stock valued at $6,717,000 after buying an additional 13,617 shares during the period. Bank Pictet & Cie Europe AG boosted its position in shares of Procter & Gamble by 493.6% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 341,750 shares of the company's stock valued at $57,294,000 after buying an additional 284,174 shares during the period. Two Sigma Advisers LP boosted its position in shares of Procter & Gamble by 100.5% during the fourth quarter. Two Sigma Advisers LP now owns 110,300 shares of the company's stock valued at $18,492,000 after buying an additional 55,300 shares during the period. Two Sigma Investments LP boosted its position in shares of Procter & Gamble by 2.4% during the fourth quarter. Two Sigma Investments LP now owns 18,133 shares of the company's stock valued at $3,040,000 after buying an additional 433 shares during the period. Finally, Voloridge Investment Management LLC boosted its position in shares of Procter & Gamble by 671.8% during the fourth quarter. Voloridge Investment Management LLC now owns 209,000 shares of the company's stock valued at $35,039,000 after buying an additional 181,921 shares during the period. Hedge funds and other institutional investors own 65.77% of the company's stock.
Insider Transactions at Procter & Gamble
In related news, CEO Gary A. Coombe sold 10,194 shares of the company's stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the transaction, the chief executive officer directly owned 34,978 shares of the company's stock, valued at $5,532,120.48. This represents a 22.57% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Shailesh Jejurikar sold 13,039 shares of the company's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the sale, the chief operating officer directly owned 28,036 shares in the company, valued at approximately $4,409,221.72. The trade was a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,181 shares of company stock worth $18,918,012 over the last 90 days. Insiders own 0.20% of the company's stock.
Procter & Gamble Stock Down 0.7%
Procter & Gamble stock traded down $1.17 during mid-day trading on Friday, reaching $156.15. 17,159,888 shares of the company were exchanged, compared to its average volume of 5,803,375. The business has a fifty day moving average of $156.16 and a 200 day moving average of $161.37. The firm has a market cap of $365.47 billion, a P/E ratio of 23.99, a PEG ratio of 4.15 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business's quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble's dividend payout ratio is presently 64.98%.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. Wells Fargo & Company lowered their price target on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Berenberg Bank boosted their price target on Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a report on Wednesday. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Evercore ISI reiterated an "in-line" rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Finally, Barclays set a $164.00 price target on Procter & Gamble and gave the company an "equal weight" rating in a report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $173.94.
Read Our Latest Stock Analysis on Procter & Gamble
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
